Valneva SE (VALN) Financials

VALN Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 551.1 million 384.3 million
2023-06-30 590.0 million 382.6 million
2023-03-31 643.1 million 419.9 million
2022-12-31 666.8 million 430.9 million

VALN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -76.9 million ?
2023-06-30 -48.4 million ?
2023-03-31 -30.7 million ?
2022-12-31 -67.2 million ?

VALN Net Income

No data available :(

VALN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 181.3 million - 56.8 million
2023-06-30 222.3 million - 58.5 million
2023-03-31 - - 60.3 million
2022-12-31 310.6 million - 57.5 million

VALN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 143.2 million
2023-06-30 153.2 million
2023-03-31 76.0 million
2022-12-31 149.0 million

VALN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 1.3 million 17.2 million 12.9 million 14.7 million
2023-06-30 3.7 million 13.0 million 14.0 million 12.0 million
2023-03-31 4.2 million 15.3 million 10.9 million 9.8 million
2022-12-31 7.3 million 31.7 million 11.6 million 11.2 million

VALN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 40.3 million 22.2 million
2023-06-30 43.7 million 36.3 million
2023-03-31 36.5 million 22.3 million
2022-12-31 119.6 million 130.6 million

VALN

Price: $7.57

52 week price:
6.58
17.05

Earnings Per Share: -1.58 USD

P/E Ratio: -4.83

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 8187

Market Capitalization: 571.8 million

Links: